# EDGAR Filing Document

**Accession Number:** 0001859795
**File Stem:** 0000950170-25-098570
**Filing Date:** 2025-7
**Character Count:** 77096
**Document Hash:** 1e2a721a998cae9e29cdc0a35cf60211
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000950170-25-098570.hdr.sgml**: 20250725

**ACCESSION NUMBER**: 0000950170-25-098570

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 9

**CONFORMED PERIOD OF REPORT**: 20250725

**FILED AS OF DATE**: 20250725

**DATE AS OF CHANGE**: 20250725

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** NOVONIX Ltd
- **CENTRAL INDEX KEY:** 0001859795
- **STANDARD INDUSTRIAL CLASSIFICATION:** MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 981559131
- **STATE OF INCORPORATION:** C3
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41208
- **FILM NUMBER:** 251148571

**BUSINESS ADDRESS:**
- **STREET 1:** LEVEL 38
- **STREET 2:** 71 EAGLE STREET
- **CITY:** BRISBANE
- **STATE:** C3
- **ZIP:** 4000
- **BUSINESS PHONE:** 4235416874

**MAIL ADDRESS:**
- **STREET 1:** LEVEL 38
- **STREET 2:** 71 EAGLE STREET
- **CITY:** BRISBANE
- **STATE:** C3
- **ZIP:** 4000

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

Washington, D.C. 20549

**FORM 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE**

**SECURITIES EXCHANGE ACT OF 1934**

For the month of July, 2025

001-41208 <br> (Commission File Number)

**NOVONIX LIMITED**

(Translation of registrant's name into English)

Level 38

71 Eagle Street

Brisbane, QLD 4000 Australia

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

------

**EXHIBIT INDEX**

**<u>Exhibit No.</u> <u>Description</u>**

Exhibit 99.1 [<u>Appendix</u>](nvx-ex99_1.htm)[<u>2A (Application for quotation of securities) dated</u>](nvx-ex99_1.htm)[<u>July 25, 2025</u>](nvx-ex99_1.htm)

Exhibit 99.2 [<u>Appendix 3G (Notification of issue, conversion or payment up of unquoted equity securities) dated July 25, 2025</u>](nvx-ex99_2.htm)

Exhibit 99.3 [<u>ASX Announcement (Cleansing Notice – Issue of First Tranche Convertible Debentures) dated July 25, 2025</u>](nvx-ex99_3.htm)

Exhibit 99.4 [<u>ASX Notice under Section 708A(5)(e) of the Corporations Act 2001 (Cth) dated July 25, 2025</u>](nvx-ex99_4.htm)

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

**NOVONIX LIMITED**<br>By: <u>/s/ Robert Long</u> <br>&nbsp;&nbsp;&nbsp;&nbsp; Robert Long<br>&nbsp;&nbsp;&nbsp;&nbsp; Chief Financial Officer<br>

Date: July 25, 2025

------

## Exhibit 99.1

---

| | |
|:---|:---|
| ![img58969013_0.jpg](img58969013_0.jpg) | Appendix 2A - Application for quotation of securities |

---

EXHIBIT 99.1

Announcement Summary

------

**Entity name**

NOVONIX LIMITED

**Announcement Type**

New announcement

**Date of this announcement**

Friday July 25, 2025

**The +securities to be quoted are:**

+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B

**Total number of +securities to be quoted**

---

| | | |
|:---|:---|:---|
| **ASX +security**  |  | **Number of +securities to**  |
| **code** | **Security description** | **be quoted Issue date**  |
| NVX | ORDINARY FULLY PAID | 783,867 25/07/2025 |

---

Refer to next page for full details of the announcement

<br> Appendix 2A - Application for quotation of securities 1/6

------

---

| | |
|:---|:---|
| ![img58969013_0.jpg](img58969013_0.jpg) | Appendix 2A - Application for quotation of securities |

---

Part 1 - Entity and announcement details

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1 Name of entity**

NOVONIX LIMITED

We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.

---

| | |
|:---|:---|
| **1.2 Registered number type** | **Registration number** |
| ACN | 157690830 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.3 ASX issuer code**

NVX

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.4 The announcement is**

New announcement

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.5 Date of this announcement**

25/7/2025

<br> Appendix 2A - Application for quotation of securities 2/6

------

---

| | |
|:---|:---|
| ![img58969013_0.jpg](img58969013_0.jpg) | Appendix 2A - Application for quotation of securities |

---

Part 2 - Type of Issue

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.1 The +securities to be quoted are:**

+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B

**Previous Appendix 3B details:**

---

| | | |
|:---|:---|:---|
| **Announcement Date and Time** | **Announcement Title** | **Selected Appendix 3B to submit quotation request** |
| **Announcement Date and Time** |  | **Selected Appendix 3B to submit quotation request** |
| 24-Jul-2025 09:07 | New - Proposed issue of securities - <br>NVX | A placement or other type of issue |
|  | New - Proposed issue of securities - <br>NVX |  |

---

**2.3a.2 Are there any further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B?**

Yes

**2.3a.3 Please provide details of the further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B**

<u>Issue of convertible debentures.</u>

<br> Appendix 2A - Application for quotation of securities 3/6

------

---

| | |
|:---|:---|
| ![img58969013_0.jpg](img58969013_0.jpg) | Appendix 2A - Application for quotation of securities |

---

Part 3A - number and type of +securities to be quoted where issue has previously been notified to ASX in an Appendix 3B

------

Placement Details

------

**ASX +security code and description**

NVX : ORDINARY FULLY PAID

**Issue date**

25/7/2025

Distribution Schedule

------

**Provide a distribution schedule for the new +securities according to the categories set out in the left hand column - including the number of recipients and the total percentage of the new +securities held by the recipients in each category.**

---

| | | |
|:---|:---|:---|
| <br>**Number of +securities held** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>**Number of holders** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total percentage of +securities held**<br>For example, to enter a value of 50% |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;please input as 50.00 |
| 1 - 1000 |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;% |
| <br>1001 - 5000 |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; % |
| <br>5001 - 10000 |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; % |
| <br>10001 - 100000 |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; % |
| <br>100,001 and over |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; % |

---

<br> Appendix 2A - Application for quotation of securities 4/6

------

---

| | |
|:---|:---|
| ![img58969013_0.jpg](img58969013_0.jpg) | Appendix 2A - Application for quotation of securities |

---

Issue details

------

**Number of +securities to be quoted**

783,867

**Are the +securities being issued for a cash consideration?**

No

**Please describe the consideration being provided for the +securities**

<u>Prepayment of the first three months of interest payable on the First Drawdown Convertible Debentures.</u>

**Please provide an estimate (in AUD) of the value of the consideration being provided per +security for the**

**+securities to be quoted**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.585000 **Any other information the entity wishes to provide about the +securities to be quoted**

------

<br> Appendix 2A - Application for quotation of securities 5/6

------

---

| | |
|:---|:---|
| ![img58969013_0.jpg](img58969013_0.jpg) | Appendix 2A - Application for quotation of securities |

---

Part 4 - Issued capital following quotation

------

**Following the quotation of the +securities the subject of this application, the issued capital of the entity will comprise:**

The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the**

**+securities subject of this application)**

---

| | |
|:---|:---|
| **ASX +security code and description** | **Total number of**<br>**+securities on issue** |
| NVX : ORDINARY FULLY PAID | 637229503 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX)**

---

| | |
|:---|:---|
| **ASX +security code and description** | **Total number of**<br>**+securities on issue** |
| NVXAD : PERFORMANCE RIGHTS | 29000971 |
| NVXAA : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14016667 |
| NVXAB : SHARE RIGHTS | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1008567 |
| NVXAL : CONVERTIBLE NOTES | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;45221586 |

---

<br> Appendix 2A - Application for quotation of securities 6/6

------

## Exhibit 99.2

---

| | |
|:---|:---|
| ![img59892534_0.jpg](img59892534_0.jpg) | Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities |

---

EXHIBIT 99.2

Announcement Summary

------

**Entity name**

NOVONIX LIMITED

**Date of this announcement**

Friday July 25, 2025

**The +securities the subject of this notification are:**

+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B that are not quoted, and are not intended to be quoted, on ASX

**Total number of +securities to be issued/transferred**

---

| | | |
|:---|:---|:---|
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;**Total number of** |
| **ASX +security** |  | &nbsp;&nbsp;&nbsp;&nbsp;**+securities to be**  |
| **code** | **Security description** | **issued/transferred Issue date** |
| New class - code | Convertible debentures | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;24,500,000 25/07/2025 |
| to be confirmed |  |  |

---

Refer to next page for full details of the announcement

<br> Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities 1 / 7

------

---

| | |
|:---|:---|
| ![img59892534_0.jpg](img59892534_0.jpg) | Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities |

---

Part 1 - Entity and announcement details

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.1 Name of entity**

NOVONIX LIMITED

We (the entity named above) give notice of the issue, conversion or payment up of the following unquoted +securities.

---

| | |
|:---|:---|
| **1.2 Registered number type** | **Registration number** |
| ACN | 157690830 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.3 ASX issuer code**

NVX

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.4 The announcement is**

New announcement

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.5 Date of this announcement**

25/7/2025

<br> Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities 2 / 7

------

---

| | |
|:---|:---|
| ![img59892534_0.jpg](img59892534_0.jpg) | Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities |

---

Part 2 - Issue details

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.1 The +securities the subject of this notification are:**

+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B that are not quoted, and are not intended to be quoted, on ASX

**Previous Appendix 3B details:**

---

| | | |
|:---|:---|:---|
| **Announcement Date and Time** | **Announcement Title** | **Selected Appendix 3B to submit quotation request** |
| **Announcement Date and Time** |  | **Selected Appendix 3B to submit quotation request** |
| 24-Jul-2025 09:07 | New - Proposed issue of securities - NVX | A placement or other type of issue |
|  | New - Proposed issue of securities - NVX |  |

---

**2.3a.2 Are there any further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B?**

Yes

**2.3a.3 Please provide details of the further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B**

<u>Issue of second and additional tranches of convertible debentures.</u>

<br> Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities 3 / 7

------

---

| | |
|:---|:---|
| ![img59892534_0.jpg](img59892534_0.jpg) | Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities |

---

Part 3A - number and type of +securities the subject of this notification (existing class or new class) where issue has previously been notified to ASX in an Appendix 3B

Placement Details

------

**ASX +security code and description**

new unquoted class of security

**Date the +securities the subject of this notification were issued**

25/7/2025

**Any other information the entity wishes to provide about the +securities the subject of this notification**

<u>Convertible debentures</u>

Issue details

------

---

| | |
|:---|:---|
| **Number of +securities** |  |
| 24,500,000 |  |
| **Were the +securities issued for a cash consideration?** |  |
| Yes |  |
| **In what currency was the cash consideration being paid?** | **What was the issue price per +security?** |
| **In what currency was the cash consideration being paid?** |  |
| USD - US Dollar | USD 0.95000000 |

---

------

<br> Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities 4 / 7

------

---

| | |
|:---|:---|
| ![img59892534_0.jpg](img59892534_0.jpg) | Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities |

---

Part 3C - number and type of +securities the subject of this notification (new class)

------

---

| | |
|:---|:---|
| **ASX +security code** | **+Security description** |
| New class - code to be confirmed | &nbsp;&nbsp;Convertible debentures |
| **+Security type**<br>+Convertible debt securities | **ISIN code** |

---

**Date the +securities the subject of this notification were issued**

25/7/2025

**Will all the +securities issued in this class rank equally in all respects from their issue date?**

Yes

**Have you received confirmation from ASX that the terms of the +securities are appropriate and equitable under listing rule 6.1?**

No

**Please provide a URL link for a document lodged with ASX setting out the material terms of the +securities being issued.**

<u>https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02970402-2A1609711&v=4a466cc3f89 9e00730cfbfcd5ab8940c41f474b6</u>

+Convertible debt securities Details

------

**Type of +security**

Convertible note or bond

---

| | | |
|:---|:---|:---|
| **+Security currency**<br>USD - US Dollar | **Face value**<br>USD 1.00000000 | **Interest rate type**<br>Fixed rate |
| **Frequency of coupon/interest payments per year**<br>Semi-annual | **Frequency of coupon/interest payments per year**<br>Semi-annual | **First interest payment date** |

---

---

| | |
|:---|:---|
| **Interest rate per annum**<br>5.00% | **Is the interest rate per annum estimated at this time?**<br>No |

---

**s128F of the Income Tax Assessment Act status applicable to the +security**

s128F exemption status unknown

---

| | |
|:---|:---|
| **Is the +security perpetual (i.e. no maturity)?**<br>No | **Maturity date**<br>25/1/2027 |

---

---

| | |
|:---|:---|
| **Select other feature(s) applicable to the +security** |  |
| Redeemable |  |
| **Is there a first trigger date on which a right of conversion, redemption, call or put can be exercised (whichever is first)?** | **If yes, what is the first trigger date?** |
| Yes | 26/7/2025 |

---

<br> Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities 5 / 7

------

---

| | |
|:---|:---|
| ![img59892534_0.jpg](img59892534_0.jpg) | Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities |

---

**Details of the existing class of +security that will be issued if the securities are converted, transformed or exchanged**

NVX : ORDINARY FULLY PAID

**Any other information the entity wishes to provide about the +securities the subject of this notification**

Issue details

------

**Number of +securities**

24,500,000

------

<br> Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities 6 / 7

------

---

| | |
|:---|:---|
| ![img59892534_0.jpg](img59892534_0.jpg) | Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities |

---

Part 4 - +Securities on issue

------

**Following the issue, conversion or payment up of the +securities the subject of this notification, the +securities of the entity will comprise:**

The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**4.1 Quoted +securities (Total number of each +class of +securities issued and quoted on ASX)** 

---

| | |
|:---|:---|
| **ASX +security code and description** | **Total number of**<br>**+securities on issue** |
| NVX : ORDINARY FULLY PAID | 636445636 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**4.2 Unquoted +securities (Total number of each +class of +securities issued but not quoted on ASX)**

---

| | |
|:---|:---|
| <br>**ASX +security code and description** | **Total number of**<br>**+securities on issue** |
| NVXAD : PERFORMANCE RIGHTS | 29000971 |
| NVXAA : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES | 14016667 |
| NVXAB : SHARE RIGHTS | 1008567 |
| NVXAL : CONVERTIBLE NOTES | 45221586 |
| New class - code to be confirmed : Convertible debentures | 24500000 |

---

<br> Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities 7 / 7

------

## Exhibit 99.3

![img60816055_0.jpg](img60816055_0.jpg)<br>

**ASX ANNOUNCEMENT**

(ASX: **NVX**)

**EXHIBIT 99.3**

25 July 2025

**Cleansing Notice – Issue of First Tranche Convertible Debentures**

**1** **Purpose of this notice**

This cleansing notice (***Cleansing Notice***) is given by NOVONIX Limited (ACN 157 690 830) (ASX:NVX) (***Company***) under section 708A(12C)(e) of the *Corporations Act 2001* (Cth) (***Corporations Act***) (as notionally inserted by *ASIC Corporations* (*Sale Offers: Securities Issued on Conversion of Convertible Notes) Instrument 2016/82* (***ASIC Instrument 2016/82***)).

The Company hereby confirms that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)the convertible debentures described below will be issued without disclosure to an investor under Part 6D.2 of the Corporations Act; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)this Cleansing Notice has been given in accordance with section 708A(12C)(e) of the Corporations Act.

The issue of this Cleansing Notice enables the fully paid ordinary shares in the capital of the Company (***Shares***) issued on the conversion of the unsecured convertible debentures issued by the Company on the terms described below, to be on-sold to retail investors without further disclosure.

This Cleansing Notice is important and should be read in its entirety. Neither ASIC nor ASX takes any responsibility for the contents of this Cleansing Notice.

**2** **Background**

On 23 July 2025, the Company announced that it has entered into a convertible debenture transaction with Yorkville Advisors Global, LP, documented under a funding agreement (***Agreement***) with YA II PN, Ltd (***Investor***), a US-based investment fund managed by Yorkville Advisors Global, LP.

The Company will issue the Investor up to 100,000,000 interest-bearing redeemable unsecured convertible debentures each at a face value of US$1 (***Convertible Debentures***), comprising:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)the first tranche of 24,500,000 Convertible Debentures to raise up to a total of US$23,275,000 (***First Tranche Convertible Debentures***); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)subject to the Company obtaining shareholder approval, the second tranche of 35,500,000 Convertible Debentures to raise up to a total of US$33,725,000 (***Second Tranche Convertible Debentures***),

for consideration, in aggregate, of up to US$57,000,000; and

---

| | |
|:---|:---|
| **NOVONIX Limited** (ASX: NVX) <br>ACN 157 690 830<br>Level 38, 71 Eagle Street<br>Brisbane QLD 4000<br>AUSTRALIA<br>| page 1 |

---

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)subject to the Company obtaining shareholder approval, an additional tranche of 40,000,000 Convertible Debentures, in connection with a potential additional funding tranche, to raise up to a further US$38,000,000 (***Additional Tranche Convertible Debentures***),

subject to the terms of the Agreement.

The Investor is a professional investor or sophisticated investor for the purposes of section 708 of the Corporations Act.

The First Tranche Convertible Debentures have been issued today. The issuance and conversion of the First Tranche Convertible Debentures utilised the Company's existing 15% placement capacity under ASX Listing Rule 7.1 and accordingly shareholder approval has not been sought for the issue. The Investor's ability to convert the First Tranche Convertible Debentures is subject to a conversion cap on the amount of underlying shares being issued on conversion not exceeding 95,466,845 Shares, unless and until shareholder approval is obtained (***Conversion Cap***). This number corresponds to the number of shares that the Company can currently issue under Listing Rule 7.1 without needing to obtain shareholder approval.

The issue of the Second Tranche Convertible Debentures and the Additional Tranche Convertible Debentures is subject to shareholder approval. The Second Tranche Convertible Debentures and the Additional Tranche Convertible Debentures will be issued on or around the time that shareholder approval is obtained at an Extraordinary General Meeting of the Company expected to be held on 9 September 2025 and the Company expects to provide a cleansing notice in connection with the issuance of the Second Tranche Convertible Debentures and the Additional Tranche Convertible Debentures at such time.

**3** **Contents of this Cleansing Notice**

3.1This Cleansing Notice sets out the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)In relation to the First Tranche Convertible Debentures:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)the effect of the issue on the Company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)a summary of the rights and liabilities attaching to the First Tranche Convertible Debentures; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)a summary of the rights and liabilities attaching to the Shares that will be issued on the conversion of the First Tranche Convertible Debentures; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Any information that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)has been excluded from continuous disclosure notices in accordance with the ASX Listing Rules; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)is information that investors and their professional advisors would reasonably require for the purpose of making an informed assessment of:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)the assets and liabilities, financial position and performance, profits and losses and prospects of the Company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)the rights and liabilities attaching to the Shares; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)other information relating to the Company's status as a disclosing entity.

---

| | |
|:---|:---|
| **NOVONIX Limited** (ASX: NVX) <br>ACN 157 690 830<br>Level 38, 71 Eagle Street<br>Brisbane QLD 4000<br>AUSTRALIA<br>| page 2 |

---

------

**4** **The effect of the issue on the Company**

4.1**Effect of the issue on the Company**

The principal effects of the issue, and any subsequent conversion and issue of Shares, of the First Tranche Convertible Debentures on the Company will be:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)an increase in the Company's cash reserves by US$23,275,000 (before other costs associated with the issue);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)an increase in the Company's indebtedness by an amount equal to US$23,275,000 plus all accrued and unpaid interest;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)to impose on the Company obligations (financial or otherwise) and restrictions in relation to its business operations (including capital raising activities) aimed at protecting the interests of the Investor under the terms of the Agreement;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)if the Investor elects to convert the First Tranche Convertible Debentures to Shares, either in whole or in part, the Investor will be issued the Shares and the Company will decrease its indebtedness accordingly. The potential effect of the conversion and the issue of Shares on the Company's capital structure is described in further detail below.

4.2**Pro-forma consolidated statement of financial position**

A pro-forma consolidated statement of financial position is set out in Schedule 1. This is based on the Company's financial statements for the full year period ended 31 December 2024.

The following adjustments and assumptions have been made in relation to the pro-forma consolidated statement of financial position:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•The pro forma financial information is presented in an abbreviated form and does not include all of the disclosures required by Australian Accounting Standards applicable to the annual financial report. The pro forma financial information is not audited.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Cash proceeds of up to US$23,275,000 arising from the issue of the First Tranche Convertible Debentures have been recognised. The First Tranche Convertible Debentures have been provisionally measured at fair value.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•The provisional accounting for the First Tranche Convertible Debentures and allocations between borrowings, derivative financial instruments and equity may change in the future.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Transaction costs have not been included. However, when incurred they will reduce the carrying amount of the liability and be amortised over the life of the First Tranche Convertible Debentures.

The pro-forma consolidated statement of financial position reflects the issue of the First Tranche Convertible Debentures, and the Company advises that it does not show the current financial position of the Company as at the date of this Cleansing Notice, and that the information is provided for illustrative purposes only.

A separate pro-forma consolidated statement of financial position, reflecting the issue of the Second Tranche Convertible Debentures and the Additional Tranche Convertible Debentures, will be included in the cleansing notice in connection with the issue of those Convertible Debentures.

---

| | |
|:---|:---|
| **NOVONIX Limited** (ASX: NVX) <br>ACN 157 690 830<br>Level 38, 71 Eagle Street<br>Brisbane QLD 4000<br>AUSTRALIA<br>| page 3 |

---

------

4.3**Potential effect on capital structure**

The capital structure of the Company as at the date of this Cleansing Notice and before the issue of the First Tranche Convertible Debentures is set out below.

The effect of conversion of the First Tranche Convertible Debentures on the Company's issued share capital will depend on what portion (if any) of the First Tranche Convertible Debentures are converted to Shares at any one time and the conversion price at the time of the conversion. The number of Shares to be issued upon any conversion is calculated in accordance with a variable formula which depends on both the market price of the Shares on ASX and the AUD/USD exchange rate at the time of conversion. This is subject to a lower limit (based on the "Fixed Conversion Price" of AU$0.6435 per Share) and an upper limit (being a "Floor Price" of AU$0.12 per Share).

As at the date of this Cleansing Notice, no First Tranche Convertible Debentures have been converted.

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;**Type of security** | &nbsp;&nbsp;**Securities on issue as at the date of this Cleansing Notice** | &nbsp;&nbsp;**Number on issue assuming maximum conversion of the First Tranche Convertible Debentures**<sup>1</sup> |
| &nbsp;&nbsp;Fully paid ordinary shares | &nbsp;&nbsp;636445636 | &nbsp;&nbsp;946,399,586\* |
| &nbsp;&nbsp;Performance rights | &nbsp;&nbsp;29000971 | &nbsp;&nbsp;29000971 |
| &nbsp;&nbsp;Share rights | &nbsp;&nbsp;1008567 | &nbsp;&nbsp;1008567 |
| &nbsp;&nbsp;Share options | &nbsp;&nbsp;14016667 | &nbsp;&nbsp;14016667 |
| &nbsp;&nbsp;Existing Convertible Notes | &nbsp;&nbsp;45,221,586\*\* | &nbsp;&nbsp;45221586 |
| &nbsp;&nbsp;First Tranche Convertible Debentures | &nbsp;&nbsp;24,500,000\*\*\* | &nbsp;&nbsp;0 |

---

**\* This assumes conversion at the lowest possible conversion price under the Agreement, assuming an AUD:USD exchange rate of 0.6587. The actual number of Shares to be issued on conversion will be calculated in accordance with the conversion rate for the First Tranche Convertible Debentures, as detailed in Schedule 2.**

**\*\* These are the US$30,000,000 worth of unsecured convertible notes issued to LG Energy Solution on 21 June 2023.**

**\*\*\* These are the First Tranche Convertible Debentures which are the subject of this Cleansing Notice.**

Set out below is a worked example of the number of Shares that may be issued on conversion of the First Tranche Convertible Debentures, assuming an AUD:USD exchange rate of 0.6587, and based on assumed conversion prices of AU$0.6435 (being the "Fixed Conversion Price"), AU$0.4424 (which is representative of the 90-day VWAP of the Shares on ASX immediately preceding the date of this Cleansing Notice) and AU$0.12 (being the "Floor Price").

------

<sup>1</sup> The Investor's ability to convert the First Tranche Convertible Debentures is subject to a conversion cap on the amount of underlying shares being issued on conversion not exceeding 95,466,845Shares, unless and until shareholder approval is obtained.

---

| | |
|:---|:---|
| **NOVONIX Limited** (ASX: NVX) <br>ACN 157 690 830<br>Level 38, 71 Eagle Street<br>Brisbane QLD 4000<br>AUSTRALIA<br>| page 4 |

---

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;**Assumed Conversion Price** | &nbsp;&nbsp;**Shares on issue as at the date of this Cleansing Notice** | &nbsp;&nbsp;**Maximum number of Shares which may be issued** \* | &nbsp;&nbsp;**Shares on issue after maximum conversion** | &nbsp;&nbsp;**Dilutive effect on existing shareholders** |
| &nbsp;&nbsp;AU$0.6435 | &nbsp;&nbsp;636445636 | &nbsp;&nbsp;57800270 | &nbsp;&nbsp;694245906 | &nbsp;&nbsp;8.33% |
| &nbsp;&nbsp;AU$0.4424  | &nbsp;&nbsp;636445636 | &nbsp;&nbsp;84074308 | &nbsp;&nbsp;720519944 | &nbsp;&nbsp;11.67% |
| &nbsp;&nbsp;AU$0.12 | &nbsp;&nbsp;636445636 | &nbsp;&nbsp;309953950 | &nbsp;&nbsp;946399586 | &nbsp;&nbsp;32.75% |

---

**These workings are an example only, and the actual number of First Tranche Convertible Debentures that are converted to Shares and the number of Shares on issue at the time of conversion, may differ. This will result in the maximum number of Shares to be issued and the dilution percentage to also differ.**

4.4**Potential effect on control of the Company**

As at the date of this Cleansing Notice, the Investor does not hold any Shares.

The level of ownership of Shares by the Investor, if the First Tranche Convertible Debentures are converted, will depend on the number of First Tranche Convertible Debentures that are converted to Shares and the number of Shares on issue at the time of conversion. The number of Shares that could be issued upon conversion is subject to a lower limit (based on the "Fixed Conversion Price" of AU$0.6435 per Share) and an upper limit (being a "Floor Price" of AU$0.12 per Share). This is designed, in part, to limit the dilutionary impacts of any conversion of the Convertible Debentures.

If conversion of the First Tranche Convertible Debentures occurred at the Floor Price, this would result in the maximum number of Shares that the Investor would be entitled to upon such conversion, and in such circumstances the Investor would hold 32.75% of all Shares currently on issue. This would require that the price of the Shares on ASX reduced to a price below AU$0.12 at the time of conversion, which represents a 79.49% discount to the price of the Shares on ASX on 23 July 2025.

In addition, under the Agreement, there are limits to how many Shares the Investor can be issued upon Conversion which will limit the potential effect on control of the Company, namely:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•The First Tranche Convertible Debentures are initially subject to a Conversion Cap of 95,466,845 Shares. If all of these Shares were issued to the Investor, this would represent 14.99% of all Shares currently on issue; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•at all times, the Investor and any associates of the Investor are not permitted to convert any Convertible Debentures if on doing so the Investor and its associates would hold a relevant interest in the Company that exceeds 19.99% at the time of conversion.

**5** **Rights and liabilities attaching to the Convertible Debentures**

A summary of the rights, privileges and restrictions attaching to the First Tranche Convertible Debentures is outlined in the table in Schedule 2. The summary is not exhaustive and does not constitute a definitive statement of the rights and liabilities of the Investor.

---

| | |
|:---|:---|
| **NOVONIX Limited** (ASX: NVX) <br>ACN 157 690 830<br>Level 38, 71 Eagle Street<br>Brisbane QLD 4000<br>AUSTRALIA<br>| page 5 |

---

------

**6** **Rights and liabilities attaching to Shares issued on conversion of the Convertible Debentures**

The Shares issued to the Investor on the conversion of the First Tranche Convertible Debentures under the Agreement will be fully paid ordinary shares in the capital of the Company, having all the rights set out in the Company's constitution.

A summary of the rights and liabilities attaching to Shares, including the Shares to be issued to the Investors on conversion of the Convertible Debentures, is set out below.

The summary is not exhaustive and does not purport to constitute a definitive statement of the rights and liabilities of Shareholders and is qualified by the terms of the Company's Constitution (a full copy of which is available from the Company on request free of charge).

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Summary of the rights and liabilities attaching to Shares issued on conversion of the First Tranche Convertible Debentures** | &nbsp;&nbsp;**Summary of the rights and liabilities attaching to Shares issued on conversion of the First Tranche Convertible Debentures** |
| &nbsp;&nbsp;**General meetings** | &nbsp;&nbsp;Each shareholder of the Company (***Shareholder***) is entitled to be present in person, or by proxy, attorney or representative to attend and vote at general meetings of the Company.<br>Shareholders may requisition meetings in accordance with section 249D of the Corporations Act and the constitution of the Company (***Constitution***). |
| &nbsp;&nbsp;**Voting rights** | &nbsp;&nbsp;Subject to any rights or restrictions for the time being attached to any class or classes of shares, at general meetings of shareholders or classes of shareholders:<br>•each Shareholder entitled to vote may vote in person or by proxy, attorney or representative;<br>•on a show of hands, every person present who is a Shareholder or a proxy, attorney or representative of a Shareholder has one vote; and<br>•on a poll, every person present who is a Shareholder or a proxy, attorney or representative of a Shareholder shall, in respect of each fully paid Share held by him, or in respect of which he is appointed a proxy, attorney or representative, have one vote for each Share held, but in respect of partly paid shares shall have such number of votes as bears the same proportion to the total of such Shares registered in the Shareholder's name as the amount paid (not credited) bears to the total amounts paid and payable (excluding amounts credited). |
| &nbsp;&nbsp;**Ranking of Shares** | &nbsp;&nbsp;At the date of this Cleansing Notice, all shares are of the same class and rank equally in all respects. |
| &nbsp;&nbsp;**Variation of rights** | &nbsp;&nbsp;Subject to the Corporations Act and the terms of issue of a class of shares, wherever the capital of the Company is divided into  |

---

---

| | |
|:---|:---|
| **NOVONIX Limited** (ASX: NVX) <br>ACN 157 690 830<br>Level 38, 71 Eagle Street<br>Brisbane QLD 4000<br>AUSTRALIA<br>| page 6 |

---

------

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Summary of the rights and liabilities attaching to Shares issued on conversion of the First Tranche Convertible Debentures** | &nbsp;&nbsp;**Summary of the rights and liabilities attaching to Shares issued on conversion of the First Tranche Convertible Debentures** |
|  | &nbsp;&nbsp;different classes of shares, the rights attached to any class of shares may be varied:<br>•with the written consent of the holders of at least 75% of the issued shares in the particular class; or<br>•by a special resolution passed at a separate meeting of the holders of shares in that class. |
| &nbsp;&nbsp;**Dividend rights** | &nbsp;&nbsp;The Board may declare or determine that a dividend is payable on Shares. The Board may fix the amount of the dividend, the time for determining entitlements to the dividend, the time for the payment of the dividend and the method of payment of the dividend. <br>If a dividend is declared or determined to be payable, Shareholders will be entitled to dividends, distributed among members in proportion to the capital paid up, from the date of payment. |
| &nbsp;&nbsp;**Transfer of Shares** | &nbsp;&nbsp;Shares can be transferred by a proper instrument of transfer. <br>The instrument of transfer must be in writing or any other form approved by the Directors, and signed by the transferor and the transferee. Except where the operating rules of an applicable CS facility licensee, being the ASTC Operating Rules provide otherwise, until the transferee has been registered, the transferor is deemed to remain the holder of the Shares, even after signing the instrument of transfer. <br>In some circumstances, the Directors may refuse to register a transfer if on registration the transferee will hold less than a marketable parcel. The Board may refuse to register a transfer of shares on which the Company has a lien. |
| &nbsp;&nbsp;**Rights on winding up** | &nbsp;&nbsp;If the Company is wound up, the liquidator may with the sanction of a special resolution, divide the assets of the Company amongst Shareholders as the liquidator sees fit. The liquidator may not require a Shareholder to accept any Shares or other securities in respect of which there is any liability. |

---

**7** **Compliance with disclosure obligations**

7.1The Company is a 'disclosing entity' under the Corporations Act and, as such, is subject to regular reporting and disclosure obligations under both the Corporations Act and the ASX Listing Rules.

7.2Broadly, these obligations require:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)the Company to notify ASX immediately of any information (subject to certain exceptions) of which it is or becomes aware which a reasonable person would expect to have a

---

| | |
|:---|:---|
| **NOVONIX Limited** (ASX: NVX) <br>ACN 157 690 830<br>Level 38, 71 Eagle Street<br>Brisbane QLD 4000<br>AUSTRALIA<br>| page 7 |

---

------

material effect on the price value of its securities. That information is available to the public from ASX; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)the preparation of yearly and half-yearly financial statements and a report of the Company's operations during the relevant accounting period, together with an audit or review report prepared by the Company's auditor. These documents are lodged with ASIC and ASX.

7.3The Company is dual listed on the NASDAQ. A NASDAQ listed company is required to promptly disclose "any material information that would reasonably be expected to affect the value of its securities or influence investors' decisions." The Company is a '*foreign private issuer*', as defined in the Securities and Exchange Commission's (***SEC***) rules and regulations and an *'emerging growth company'* as defined in the JOBS Act. Consequently, the Company is not subject to all of the disclosure requirements applicable to public companies organised within the United States and other various reporting requirements.

7.4Copies of documents lodged by the Company in connection with its reporting and disclosure obligations may be obtained from, or inspected at, an office of ASIC. Copies of all documents announced to the ASX can be found at https://www2.asx.com.au/markets/trade-our-cash-market/announcements.nvx.

7.5The Company will provide a copy of each of the following documents, free of charge, to any person on request:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)The annual financial report most recently lodged by the Company with ASIC, being the full year financial report of the Company for the 12 months ended 31 December 2024;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)The sustainability report most recently lodged by the Company with ASIC, being the sustainability report of the Company dated 31 March 2025;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)Any half-year financial report lodged by the Company with ASIC after lodgement of the annual financial report referred to in paragraph (a) and before the lodgement of this Cleansing Notice with ASX; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)Any continuous disclosure notices given by the Company to ASX after the lodgement of the annual financial report referred to in paragraph (a) and before the lodgement of this Cleansing Notice with ASX.

7.6The continuous disclosure notices given by the Company to notify ASX of information relating to the Company during the period from the date of lodgement of the Annual Financial Report lodged with ASX on 28 February 2025, until the date of this Cleansing Notice include:

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Date**  | &nbsp;&nbsp;**Announcement** |
| &nbsp;&nbsp;25/07/2025 | &nbsp;&nbsp;Application for quotation of securities - NVX |
| &nbsp;&nbsp;25/07/2025 | &nbsp;&nbsp;Notification regarding unquoted securities - NVX |
| &nbsp;&nbsp;24/07/2025 | &nbsp;&nbsp;Proposed issue of securities - NVX |
| &nbsp;&nbsp;24/07/2025 | &nbsp;&nbsp;Quarterly Activities/Appendix 4C Cash Flow Report |
| &nbsp;&nbsp;24/07/2025 | &nbsp;&nbsp;NVX Announces Entry into Funding Agreement with Yorkville |

---

---

| | |
|:---|:---|
| **NOVONIX Limited** (ASX: NVX) <br>ACN 157 690 830<br>Level 38, 71 Eagle Street<br>Brisbane QLD 4000<br>AUSTRALIA<br>| page 8 |

---

------

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Date**  | &nbsp;&nbsp;**Announcement** |
| &nbsp;&nbsp;18/07/2025 | &nbsp;&nbsp;Application for quotation of securities - NVX |
| &nbsp;&nbsp;18/07/2025 | &nbsp;&nbsp;93.5% Antidumping Tariff on Chinese Graphite-Tariff to 160% |
| &nbsp;&nbsp;02/07/2025 | &nbsp;&nbsp;Notification regarding unquoted securities - NVX |
| &nbsp;&nbsp;30/06/2025 | &nbsp;&nbsp;Application for quotation of securities - NVX |
| &nbsp;&nbsp;25/06/2025 | &nbsp;&nbsp;Application for quotation of securities - NVX |
| &nbsp;&nbsp;18/06/2025 | &nbsp;&nbsp;Notification regarding unquoted securities - NVX |
| &nbsp;&nbsp;11/06/2025 | &nbsp;&nbsp;NOVONIX Announces Board Leadership Changes |
| &nbsp;&nbsp;05/06/2025 | &nbsp;&nbsp;Application for quotation of securities - NVX |
| &nbsp;&nbsp;04/06/2025 | &nbsp;&nbsp;Notification of cessation of securities - NVX |
| &nbsp;&nbsp;29/05/2025 | &nbsp;&nbsp;Becoming a substantial holder |
| &nbsp;&nbsp;22/05/2025 | &nbsp;&nbsp;U.S. to Place Up to 721% Tariffs on Chinese Graphite |
| &nbsp;&nbsp;13/05/2025 | &nbsp;&nbsp;Application for quotation of securities - NVX |
| &nbsp;&nbsp;02/05/2025 | &nbsp;&nbsp;Notification regarding unquoted securities - NVX |
| &nbsp;&nbsp;30/04/2025 | &nbsp;&nbsp;Quarterly Activities/Appendix 4C Cash Flow Report |
| &nbsp;&nbsp;30/04/2025 | &nbsp;&nbsp;NOVONIX Finalises PSA for Enterprise South Land |
| &nbsp;&nbsp;29/04/2025 | &nbsp;&nbsp;Change of Director's Interest Notice |
| &nbsp;&nbsp;29/04/2025 | &nbsp;&nbsp;Change of Director's Interest Notice |
| &nbsp;&nbsp;29/04/2025 | &nbsp;&nbsp;Change of Director's Interest Notice |
| &nbsp;&nbsp;29/04/2025 | &nbsp;&nbsp;Change of Director's Interest Notice |
| &nbsp;&nbsp;29/04/2025 | &nbsp;&nbsp;Change of Director's Interest Notice |
| &nbsp;&nbsp;29/04/2025 | &nbsp;&nbsp;Change of Director's Interest Notice |
| &nbsp;&nbsp;28/04/2025 | &nbsp;&nbsp;Notification regarding unquoted securities - NVX |
| &nbsp;&nbsp;28/04/2025 | &nbsp;&nbsp;Notification of cessation of securities - NVX |
| &nbsp;&nbsp;28/04/2025 | &nbsp;&nbsp;NVX Appoints Michael OKronley as Chief Executive Officer |
| &nbsp;&nbsp;23/04/2025 | &nbsp;&nbsp;Notification regarding unquoted securities - NVX |
| &nbsp;&nbsp;03/04/2025 | &nbsp;&nbsp;Notification of cessation of securities - NVX |
| &nbsp;&nbsp;02/04/2025 | &nbsp;&nbsp;Results of Meeting |
| &nbsp;&nbsp;02/04/2025 | &nbsp;&nbsp;CEO Presentation to the AGM |
| &nbsp;&nbsp;02/04/2025 | &nbsp;&nbsp;Chairman's Address to AGM |
| &nbsp;&nbsp;31/03/2025 | &nbsp;&nbsp;Application for quotation of securities - NVX |
| &nbsp;&nbsp;20/03/2025 | &nbsp;&nbsp;Change of Director's Interest Notice |

---

---

| | |
|:---|:---|
| **NOVONIX Limited** (ASX: NVX) <br>ACN 157 690 830<br>Level 38, 71 Eagle Street<br>Brisbane QLD 4000<br>AUSTRALIA<br>| page 9 |

---

------

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Date**  | &nbsp;&nbsp;**Announcement** |
| &nbsp;&nbsp;14/03/2025 | &nbsp;&nbsp;Change of Director's Interest Notice |
| &nbsp;&nbsp;14/03/2025 | &nbsp;&nbsp;Application for quotation of securities - NVX |
| &nbsp;&nbsp;13/03/2025 | &nbsp;&nbsp;NVX Receives Approval for Purchase of Enterprise South Land |
| &nbsp;&nbsp;04/03/2025 | &nbsp;&nbsp;Change of Director's Interest Notice |
| &nbsp;&nbsp;04/03/2025 | &nbsp;&nbsp;Change of Director's Interest Notice |
| &nbsp;&nbsp;04/03/2025 | &nbsp;&nbsp;Change of Director's Interest Notice |
| &nbsp;&nbsp;04/03/2025 | &nbsp;&nbsp;Change of Director's Interest Notice |
| &nbsp;&nbsp;04/03/2025 | &nbsp;&nbsp;Change of Director's Interest Notice |
| &nbsp;&nbsp;03/03/2025 | &nbsp;&nbsp;Notice of Annual General Meeting/Proxy Form |
| &nbsp;&nbsp;03/03/2025 | &nbsp;&nbsp;Application for quotation of securities - NVX |
| &nbsp;&nbsp;03/03/2025 | &nbsp;&nbsp;Application for quotation of securities - NVX |
| &nbsp;&nbsp;28/02/2025 | &nbsp;&nbsp;Corporate Governance Statement & Appendix 4G |
| &nbsp;&nbsp;28/02/2025 | &nbsp;&nbsp;2024 Annual Report & Appendix 4E |

---

**8** **Information excluded from continuous disclosure notices**

8.1As at the date of this Cleansing Notice, other than as set out below or elsewhere in this Cleansing Notice, the Company advise that there is no information that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)the Company has excluded from a continuous disclosure notice in accordance with the ASX Listing Rules; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)is information that investors and their professional advisers would reasonably require for the purpose of making an informed assessment of:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)the assets and liabilities, financial position and performance, profits and losses and prospects of the Company; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)the rights and liabilities attaching to the First Tranche Convertible Debentures (and the underlying Shares) offered by the Company.

**9** **Authority and Contact Details**

This announcement has been authorised for release by the NOVONIX Limited Board of Directors.

**10** **Cautionary Note Regarding Forward-Looking Statements**

This Cleansing Notice contains forward-looking statements about the Company and the industry in which we operate. Forward-looking statements can generally be identified by use of words such as "anticipate," "believe," "contemplate," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," or "would," or other similar expressions.

---

| | |
|:---|:---|
| **NOVONIX Limited** (ASX: NVX) <br>ACN 157 690 830<br>Level 38, 71 Eagle Street<br>Brisbane QLD 4000<br>AUSTRALIA<br>| page 10 |

---

------

We have based such statements on our current expectations and projections about future events and trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Such forward-looking statements involve and are subject to known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Such factors include, among others, the timely deployment and scaling of our furnace technology, our ability to meet the technical specifications and demand of our existing and future customers, the accuracy of our estimates regarding market size, expenses, future revenue, capital requirements, needs and access for additional financing, the availability and impact and our compliance with the applicable terms of government support, and our ability to obtain patent rights effective to protect our technologies and processes and successfully defend any challenges to such rights and prevent others from commercializing such technologies and processes, and regulatory developments in the United States, Australia and other jurisdictions. These and other factors that could affect our business and results are included in our filings with the U.S. Securities and Exchange Commission ("SEC"), including the Company's most recent annual report on Form 20- F. Copies of these filings may be obtained by visiting our Investor Relations website at www.novonixgroup.com or the SEC's website at www.sec.gov.

Forward-looking statements are not guarantees of future performance or outcomes, and actual performance and outcomes may differ materially from those made in or suggested by the forward-looking statements contained in this Cleansing Notice. Accordingly, you should not place undue reliance on forward-looking statements. Any forward-looking statement in this Cleansing Notice is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise, except as required by law.

**11** **About NOVONIX**

NOVONIX is a leading battery technology company revolutionizing the global lithium-ion battery industry with innovative, sustainable technologies, high-performance materials, and more efficient production methods. The Company manufactures industry-leading battering cell testing equipment, is growing its high-performance synthetic graphite material manufacturing operations, and has developed a patented all-dry, zero-waste cathode synthesis process . Through advanced R&D capabilities, proprietary technology, and strategic partnerships, NOVONIX has gained a prominent position in the electric vehicle and energy storage systems battery industry and is powering a cleaner energy future.

To learn more, visit us at www.novonixgroup.com or on LinkedIn, and X.

**For NOVONIX Limited**

Scott Espenshade, ir@novonixgroup.com (investors)

Stephanie Reid, media@novonixgroup.com (media)

---

| | |
|:---|:---|
| **NOVONIX Limited** (ASX: NVX) <br>ACN 157 690 830<br>Level 38, 71 Eagle Street<br>Brisbane QLD 4000<br>AUSTRALIA<br>| page 11 |

---

------

**NOVONIX Limited (ASX: NVX)** 

ACN 157 690 830

Level 38, 71 Eagle Street

Brisbane QLD 4000

Australia

---

| | |
|:---|:---|
| **NOVONIX Limited** (ASX: NVX) <br>ACN 157 690 830<br>Level 38, 71 Eagle Street<br>Brisbane QLD 4000<br>AUSTRALIA<br>| page 12 |

---

------

**Schedule 1** **– Pro-forma Consolidated Statement of Financial Position** 

---

| | | | |
|:---|:---|:---|:---|
| **(in U.S. dollars)** | **Audited** | <br>**Proforma** | <br>**Proforma** |
|  | **Dec 31, 2024** | **adjustments** | **Dec 31, 2024** |
| ASSETS |  |  |  |
| Current assets |  |  |  |
| &nbsp;&nbsp;Cash and cash equivalents | $42557621<sup>1</sup> | 19923481 | 62481102 |
| &nbsp;&nbsp;Trade and other receivables | 8158174 | - | 8158174 |
| &nbsp;&nbsp;Inventory | 1383904 | - | 1383904 |
| &nbsp;&nbsp;Prepayments | 1700788 | 302055 | 2002843 |
| &nbsp;&nbsp;Escrow reserves | 1452187 | - | 1452187 |
| &nbsp;&nbsp;Assets classified as held for sale | 2044673 | - | 2044673 |
| Total current assets | 57297347 | 20225536 | 77522883 |
| Non-current assets |  |  |  |
| &nbsp;&nbsp;Property, plant and equipment | 149310343 | - | 149310343 |
| &nbsp;&nbsp;Right-of-use assets | 6356771 | - | 6356771 |
| &nbsp;&nbsp;Intangible assets and goodwill | 11975024 | - | 11975024 |
| &nbsp;&nbsp;Other assets | 1156056 | - | 1156056 |
| Total non-current assets | 168798194 | - | 168798194 |
| Total assets | $226095541 | 20225536 | 246321077 |
| LIABILITIES |  |  |  |
| Current liabilities |  |  |  |
| &nbsp;&nbsp;Trade and other payables | $8524141 | 1000000 | 9524141 |
| &nbsp;&nbsp;Contract liabilities | 126056 | - | 126056 |
| &nbsp;&nbsp;Lease liabilities | 522297 | - | 522297 |
| &nbsp;&nbsp;Derivative financial instruments | 5368624 | 3327711 | 8696335 |
| &nbsp;&nbsp;Borrowings | 31668810 | 15595770 | 47264580 |
| &nbsp;&nbsp;Current tax liabilities | 31966 | - | 31966 |
| Total current liabilities | 46241894 | 19923481 | 66165375 |
| Non-current liabilities |  |  |  |
| &nbsp;&nbsp;Contract liabilities | 3000000 | - | 3000000 |
| &nbsp;&nbsp;Lease liabilities | 6488119 | - | 6488119 |
| &nbsp;&nbsp;Borrowings | 32775271 | - | 32775271 |
| Total non-current liabilities | 42263390 | - | 42263390 |
| Total liabilities | 88505284 | 19923481 | 108428765 |
| Net assets | 137590257 | 302055 | 137892312 |
| EQUITY |  |  |  |
| &nbsp;&nbsp;Contributed equity | 367537075 | 302055 | 367839130 |
| &nbsp;&nbsp;Reserves | 29723162 | - | 29723162 |
| &nbsp;&nbsp;Accumulated losses | (259669980) | - | (259669980) |
| Total equity | $137590257 | 302055 | 137892312 |

---

<sup>1</sup> Cash and cash equivalents as at 30 June 2025 is US$24,820,000, as set out in the Company's Appendix 4C released to ASX on 24 July 2025. Pro forma cash and cash equivalents as at 30 June 2025 is US$44,743,481.

---

| | |
|:---|:---|
| **NOVONIX Limited** (ASX: NVX) <br>ACN 157 690 830<br>Level 38, 71 Eagle Street<br>Brisbane QLD 4000<br>AUSTRALIA<br>| page 13 |

---

------

**Schedule 2** **– Summary of rights and liabilities attaching to Convertible Debentures** 

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Topic** | &nbsp;&nbsp;**Summary** |
| &nbsp;&nbsp;**Issuer** | &nbsp;&nbsp;NOVONIX Limited (ACN 157 690 830) (***Company***) |
| &nbsp;&nbsp;**Investor** | &nbsp;&nbsp;YA II PN, Ltd (***Yorkville***) |
| &nbsp;&nbsp;**Principal amount, face value and issue price** | &nbsp;&nbsp;The Company may issue up to 100,000,000 Convertible Debentures with an aggregate face value of US$100,000,000.<br>Each Convertible Debenture will have a face value of US$1.00.<br>The Company will receive US$0.95 in funding for each Convertible Debenture issued. |
| &nbsp;&nbsp;**Amount of funds to be advanced by Investor** | &nbsp;&nbsp;Up to US$57,000,000, with an additional funding tranche of up to US$38,000,000 (or such lesser amount as the parties mutually agree), able to be drawn down by mutual agreement between the parties.<br>In total, US$95,000,000. |
| &nbsp;&nbsp;**Status** | &nbsp;&nbsp;The Convertible Debentures constitute direct, unconditional, unsecured obligations of the Company. |
| &nbsp;&nbsp;**Tranches** | &nbsp;&nbsp;The Convertible Debentures will be issued in the following tranches:<br>•24,500,000 Convertible Debentures with an aggregate face value of US$24,500,000 representing an aggregate funding amount of US$23,275,000, on or about 25 July 2025 (***First Tranche Convertible Debentures***); and<br>•subject to the Company obtaining shareholder approval for the purposes of ASX Listing Rule 7.1 and for all other purposes:<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•35,500,000 Convertible Debentures with an aggregate face value of US$35,500,000 representing an aggregate funding amount of US$33,725,000 (***Second Tranche Convertible Debentures***); and<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•40,000,000 Convertible Debentures with an aggregate face value of US$40,000,000 representing an aggregate funding amount of US$38,000,000 (***Additional Tranche Convertible Debentures***). |
| &nbsp;&nbsp;**Drawdown of funds** | &nbsp;&nbsp;An amount equal to 95% of the full-face value of the First Tranche Convertible Debentures may be drawn by the Company upon issue of the First Tranche Convertible Debentures (***First Drawdown***).<br>An amount equal to 95% of the face value of the Second Tranche Convertible Debentures may be drawn progressively, as follows:<br>•up until 180 days after the First Drawdown, the total amount drawn down by the Company on the First Drawdown Convertible Debentures  |

---

---

| | |
|:---|:---|
| **NOVONIX Limited** (ASX: NVX) <br>ACN 157 690 830<br>Level 38, 71 Eagle Street<br>Brisbane QLD 4000<br>AUSTRALIA<br>| page 14 |

---

------

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Topic** | &nbsp;&nbsp;**Summary** |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and Second Drawdown Convertible Debentures (which represents, in aggregate, US$57,000,000 in funding) must not exceed in total US$33,725,000 at any time (***Second Drawdown***); and<br>•on the date that is 180 days after the First Drawdown, the Company may draw down the balance of the First Drawdown and the Second Drawdown not yet drawn down by the Company (***Final Drawdown***).<br>At any time up until the date that is 18 months following the date that the Company obtains shareholder approval, and with mutual agreement between the Company and Yorkville, the Company may draw down up to US$38,000,000 (or such lesser amount as the parties mutually agree) (***Additional Drawdown***). If the Company and Yorkville do not mutually agree to the Additional Drawdown, the Additional Tranche Convertible Debentures will be cancelled.  |
| &nbsp;&nbsp;**Conditions Precedent** | &nbsp;&nbsp;The Second Drawdown, Final Drawdown and Additional Drawdown are conditional upon the satisfaction (or waiver) of certain conditions precedent at the time of the relevant drawdown, including:<br>•the total amount outstanding under the Convertible Debentures not exceeding 20% of the Company's market capitalisation;<br>•the minimum average daily traded volume of the Company being not less than AU$600,000 per day during any 20 Trading Days in a consecutive 30 Trading Day period;<br>•the trading price of the Shares on ASX being greater than 200% of the Floor Price (as defined below);<br>•no material adverse effect occurring or subsisting in relation to the Company at the proposed drawdown date; and<br>•customary statements and certificates being delivered by the Company to the Investor. |
| &nbsp;&nbsp;**Maturity Date** | &nbsp;&nbsp;Each First Tranche Convertible Debenture matures on the day which is 18 months after the date of the First Drawdown, unless earlier redeemed or converted.<br>Each Second Tranche Convertible Debenture:<br>•which represents the Second Drawdown matures on the day which is 18 months after the date of the Second Drawdown; and<br>•which represents the Final Drawdown matures on the day which is 18 months after the date of the Final Drawdown,<br>unless earlier redeemed or converted.<br>Each Additional Tranche Convertible Debenture matures on the day which is 18 months after the date of the Additional Drawdown, unless earlier redeemed or converted. |

---

---

| | |
|:---|:---|
| **NOVONIX Limited** (ASX: NVX) <br>ACN 157 690 830<br>Level 38, 71 Eagle Street<br>Brisbane QLD 4000<br>AUSTRALIA<br>| page 15 |

---

------

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Topic** | &nbsp;&nbsp;**Summary** |
| &nbsp;&nbsp;**Interest Rate** | &nbsp;&nbsp;5% per annum (unless an event of default has occurred and is subsisting, in which case additional default interest accrues at the rate of 13% per annum).  |
| &nbsp;&nbsp;**Interest Payment Dates**  | &nbsp;&nbsp;Semi-annually up to the Maturity Date, and upon conversion of any Convertible Debentures. |
| &nbsp;&nbsp;**Interest Equity Shares** | &nbsp;&nbsp;The Company will issue a number of Shares (***Interest Equity Shares***) to Yorkville simultaneously with the issue of the First Tranche Convertible Debentures, as prepayment of interest payable on the full-face value of the First Tranche Convertible Debentures for the first three-month period commencing on the date of the First Drawdown (***First Interest Period***).<br>The number of Interest Equity Shares to be issued is determined based on the maximum amount of interest payable on the full-face value of the First Tranche Convertible Debentures for the First Interest Period (being US$302,055) (***Base Prepayment***) divided by the closing price of the Shares on the ASX on 23 July 2025 (after applying the AUD/USD exchange rate on that date).<br>If the actual amount of interest that would otherwise be payable on the face value of the First Tranche Convertible Debentures as at the end of the First Interest Period is less than the Base Prepayment, the amount of the over payment will be deducted from any future payments of interest by the Company until there is no difference between the Base Prepayment and such actual amount. To the extent that the over payment has not been fully deducted at the end of the First Interest Period, any conversions of the First Tranche Convertible Debentures by Yorkville will be adjusted accordingly. |
| &nbsp;&nbsp;**Interest Payments** | &nbsp;&nbsp;Interest is to be paid in cash, Shares or a combination of both cash and Shares. |
| &nbsp;&nbsp;**Ranking on conversion** | &nbsp;&nbsp;Shares issued on conversion are fully paid ordinary shares in the capital of the Company (***Shares***), having all the rights set out in the Company's constitution.  |
| &nbsp;&nbsp;**Conversion by Yorkville** | &nbsp;&nbsp;Subject to the caps on conversions described below, Yorkville may elect to convert one or more Convertible Debentures into Shares at any time after the date of issue at the Conversion Price (described below), up until but excluding the date that is three Trading Days prior to the relevant Maturity Date.<br>In respect of the First Tranche Convertible Debentures, Yorkville's right to convert the First Tranche Convertible Debentures is capped at 95,466,845 Shares (less the amount of Interest Equity Shares), unless and until shareholders approve the issue of the underlying Shares. <br>In respect of the Second Tranche Convertible Debentures and the Additional Tranche Convertible Debentures, Yorkville is only entitled to convert such number of Second Tranche Convertible Debentures that represents the amounts of the Second Drawdown and Final Drawdown, and such number of Additional Tranche Convertible Debentures that represents the amount of the  |

---

---

| | |
|:---|:---|
| **NOVONIX Limited** (ASX: NVX) <br>ACN 157 690 830<br>Level 38, 71 Eagle Street<br>Brisbane QLD 4000<br>AUSTRALIA<br>| page 16 |

---

------

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Topic** | &nbsp;&nbsp;**Summary** |
|  | &nbsp;&nbsp;Additional Drawdown, that have been drawn by the Company at the time of the proposed conversion. |
| &nbsp;&nbsp;**Conversion Price** | &nbsp;&nbsp;The Conversion Price is the price equal to the greater of:<br>•the "Floor Price" of AU$0.12, which represents 20% of the closing price of the Shares on ASX on 23 July 2025 (being AU$0.585), rounded up to the nearest whole cent (***Floor Price***); and<br>•the lower of:<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•the "Variable Conversion Price", being<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•95% of the volume weighted average market price (in A$) of the Shares on the ASX in respect of a Share on any Trading Day, as reported by Bloomberg or an alternative reputable reporting platform (***VWAP***), of the Shares on ASX over the five consecutive Trading Days preceding the proposed conversion; or<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•if the total trading volume of the Shares on any Trading Day on ASX is zero, the lower of the day prior to, or after, such date; and<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•the "Fixed Price" of a price equivalent to 110% of the price of the Shares on ASX on the Trading Day immediately prior to the date of the Funding Agreement (***Fixed Conversion Price***). |
| &nbsp;&nbsp;**Conversion Price Adjustments** | &nbsp;&nbsp;The Conversion Price will be adjusted where a security structure event occurs. A security structure event includes any consolidation, subdivision or pro-rata cancellation of the Company's issued capital, payment of a dividend in Shares or distribution of Shares, and excludes rights offerings and bonus issues. |
| &nbsp;&nbsp;**Early redemption by the Company** | &nbsp;&nbsp;At any time until the date that is three months prior to the relevant maturity date, the Company may redeem all or part of the outstanding Convertible Debentures in cash at a price equal to 110% of the amount outstanding, provided that:<br>•the average of the seven daily VWAPs of the Shares on ASX preceding the proposed early redemption; and<br>•the VWAP of the Shares on ASX on the day prior to the proposed early redemption,<br>are each less than the Fixed Conversion Price. |
| &nbsp;&nbsp;**Mandatory redemption for Amortisation Event** | &nbsp;&nbsp;If an Amortisation Event occurs, the Company must redeem Convertible Debentures representing 20% of the amount outstanding at the time of the Amortisation Event by paying such amount to the Investor in cash. <br>An Amortisation Event occurs where: |

---

---

| | |
|:---|:---|
| **NOVONIX Limited** (ASX: NVX) <br>ACN 157 690 830<br>Level 38, 71 Eagle Street<br>Brisbane QLD 4000<br>AUSTRALIA<br>| page 17 |

---

------

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Topic** | &nbsp;&nbsp;**Summary** |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•the daily VWAP of the Shares on ASX on any five of any seven consecutive days is lower than the Floor Price; or <br>•the Company has issued in excess of 90,693,503 Shares. |
| &nbsp;&nbsp;**Redemption at Maturity** | &nbsp;&nbsp;Automatic redemption on the relevant Maturity Date at an amount equal to the face value of the outstanding Convertible Debentures. |
| &nbsp;&nbsp;**Negative Covenants** | &nbsp;&nbsp;Restrictions on further financial indebtedness by the Company and on entering into variable rate transactions (i.e., transactions involving the issue of convertible securities at a variable conversion rate) without Yorkville's written approval. |
| &nbsp;&nbsp;**Events of default**  | &nbsp;&nbsp;The Funding Agreement contains certain customary events of default, including:<br>•breach by the Company of any of its material obligations or negative covenants;<br>•failure by the Company to pay any cash amount due on or within five business days of its due date;<br>•failure by the Company to issue Shares to the Investor upon conversion, or failure to procure quotation of Shares;<br>•the Company becomes insolvent, or an order is made or an effective resolution passed for the winding-up or dissolution, judicial management or administration of the Company or any subsidiary; and<br>•it becomes unlawful for the Company to perform or comply with any one or more of its obligations, or for the Investor to convert any Convertible Debentures or hold any Shares.<br>Following an event of default and subject to any applicable cure period, Yorkville may declare all amounts outstanding in respect of the Convertible Debentures and all other amounts payable immediately due and payable, or may require conversion of some or all Convertible Debentures at a conversion price which is equal to 80% of the lowest daily VWAP over the 10 consecutive Trading Days preceding the conversion. |
| &nbsp;&nbsp;**Transfer Restrictions** | &nbsp;&nbsp;Yorkville may transfer Convertible Debentures to any affiliate without the Company's prior written consent to the proposed transfer, provided that the transferee agrees in writing to be bound by the Funding Agreement.  |
| &nbsp;&nbsp;**Change of Control** | &nbsp;&nbsp;If a change of control transaction results in a bidder under a takeover bid acquiring a relevant interest in at least 50% of the Shares, or an acquirer becoming entitled to acquire 100% of the Shares under a scheme of arrangement, and Yorkville has not converted or redeemed all of its Convertible Debentures, the Company may elect to redeem all of the outstanding Convertible Debentures in cash at a redemption price equal to 110% of the amount outstanding on the Convertible Debentures. |

---

---

| | |
|:---|:---|
| **NOVONIX Limited** (ASX: NVX) <br>ACN 157 690 830<br>Level 38, 71 Eagle Street<br>Brisbane QLD 4000<br>AUSTRALIA<br>| page 18 |

---

------

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Topic** | &nbsp;&nbsp;**Summary** |
| &nbsp;&nbsp;**Quotation** | &nbsp;&nbsp;The Convertible Debentures will not be quoted on ASX or any other exchange. The Company must apply to the ASX for quotation of the Shares issued upon conversion of the Convertible Debentures. |
| &nbsp;&nbsp;**Governing Law** | &nbsp;&nbsp;The Funding Agreement is governed by Western Australian law. |

---

---

| | |
|:---|:---|
| **NOVONIX Limited** (ASX: NVX) <br>ACN 157 690 830<br>Level 38, 71 Eagle Street<br>Brisbane QLD 4000<br>AUSTRALIA<br>| page 19 |

---

------

## Exhibit 99.4

![img61739576_0.jpg](img61739576_0.jpg)

EXHIBIT 99.4

25 July 2025

The Manager

Market Announcements Office

Australian Securities Exchange

Level 6, Exchange Centre

20 Bridge Street

Sydney NSW 2000

Dear Sir / Madam

**Notice under section 708A(5)(e) of the *Corporations Act 2001* (Cth)**

This notice is given by Novonix Limited (ACN 157 690 830) (***Novonix***) (ASX Code: NVX) under section 708A(5)(e) of the *Corporations Act 2001* (Cth) (the ***Act***).

Novonix has today issued 783,867 new fully paid ordinary shares (***Interest Equity Shares***) to YA II PN, Ltd (***Yorkville***), in prepayment of the maximum amount of interest payable on the full face value of 24,500,000 convertible debentures for the three-month period commencing on 25 July 2025 and ending on 23 October 2025, pursuant to a Funding Agreement entered into between Yorkville and the Company as announced to ASX on 24 July 2025.

Novonix confirms the following:

(a)The New Shares were issued without disclosure to investors under Part 6D.2 of the Act.

(b)This notice is being given under section 708A(5)(e) of the Act.

(c)As at the date of this notice, Novonix has complied with:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)the provisions of Chapter 2M of the Act as they apply to Novonix; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)sections 674 and 674A of the Act.

(d)As at the date of this notice, there is no excluded information of the type referred to in sections 708A(7) or 708A(8) of the Act that is required to be set out in this notice under section 708A(6)(e) of the Act.

Yours sincerely

**Suzanne Yeates**

**Company Secretary**

**NOVONIX Limited**

**NOVONIX Limited** (ASX: NVX)

ACN 157 690 830

Level 38, 71 Eagle Street

Brisbane QLD 4000

AUSTRALIA

------